Asep Medical inks joint venture term sheet with Sansure Biotech, preps sepsis test for launch in China

Bacteria Blood Sepsis Social

Asep Medical Holdings on Friday said that it recently signed a joint venture term sheet with Chinese medical diagnostic company Sansure Biotech.

The term sheet is a roadmap to prepare for the research, development, use, sublicensing, and commercialization of Sepset, Asep's first-generation sepsis diagnostic kit, for use in the Chinese market.

As part of the agreement, Sansure will invest in the joint venture, and Vancouver-based Asep will provide a sublicense to Sepset patent rights for the Chinese marketplace. Asep will receive a royalty when the test is marketed.

The companies are negotiating specific collaboration terms with the aim of entering into a definitive agreement in the coming months, Asep said, adding that its early sepsis diagnostic test, developed using artificial intelligence, has proven highly accurate in clinical studies.

Page 1 of 6
Next Page